In the more recent validation in cohort B from Hannover Medical School, 126 patients had a confident diagnosis of IPF and available serum samples (2014–2018) which were used for the CCL18 measurements and genotyping, and of which 101 with complete follow-up data were included in the survival analysis. The gene discussed is CCL18; the disease is idiopathic pulmonary fibrosis.